BARCLAYS PLC: Form 38.5 (b) OSMOTICA
17 Diciembre 2020 - 04:54AM
UK Regulatory
TIDMBARC
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT,
1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader BARCLAYS CAPITAL INC
Company dealt in OSMOTICA PHARMACEUTICALS PLC
Class of relevant security to which the dealings US$0.01 ordinary shares
being disclosed relate (Note 1)
Date of dealing 16 DEC 2020
2. INTERESTS AND SHORT POSITIONS
1. Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 2) Class of relevant security: ORD
Interests Short Positions Number (%) Number (%) (1) Relevant securities
owned 320 0.00% 343 0.00% (2) Derivatives (other than options): 0 0.00%
0 0.00% (3) Options and agreements to purchase/sell: 0 0.00% 0 0.00%
(4) TOTAL: 320 0.00% 343 0.00%
b. Interests and short positions in relevant securities of the
company, otherthan the class dealt in (Note 2)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap28
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale Number of Price per unit
securities
Purchase 100 5.8000 USD
Purchase 100 5.8450 USD
Purchase 101 5.9017 USD
Purchase 158 5.8760 USD
Purchase 200 5.8900 USD
Purchase 300 5.8966 USD
Purchase 942 5.8574 USD
Sale 1,901 5.8672 USD
b. Derivatives transactions (other than options
transactions)
Product name, Nature of transaction Number of relevant Price per unit
e.g. CFD (Note 5) securities (Note 6) (Note 4)
c. Options transactions in respect of existing relevant
securities
1. Writing, selling, purchasingor varying
Product Writing, Number of Exercise Type, Expiry Option money
name, selling, securities price e.g. date paid/received
e.g. purchasing, to which American, per unit
call varying the option European (Note 4)
option etc. relates etc.
(Note 7)
ii. Exercising
Product name, Number of securities Exercise price per unit (Note 4)
e.g. call option
d. Other dealings (including transactions in respect of new
securities) (Note 3)
Nature of transaction Details Price per unit
(Note 7) (if applicable) (Note 4)
Ap29
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this
should be stated.
None
Is a Supplemental Form 38.5(b) attached? (Note 8) NO
Date of disclosure 17 DEC 2020
Contact name Large Holdings Regulatory Operations
Telephone number 020 3134 7213
Name of offeree/offeror with which
connected
Nature of connection (Note 9)
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201217005477/en/
CONTACT:
BARCLAYS PLC
SOURCE: BARCLAYS PLC
Copyright Business Wire 2020
(END) Dow Jones Newswires
December 17, 2020 05:54 ET (10:54 GMT)
Barclays (LSE:BARC)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Barclays (LSE:BARC)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024